High-throughput Sequencing-based Investigation of Chronic Disease Markers and Mechanisms.

High-throughput Sequencing-based Investigation of Chronic Disease Markers and Mechanisms. PDF Author: Hua Li
Publisher: Frontiers Media SA
ISBN: 2889765598
Category : Science
Languages : en
Pages : 161

Get Book Here

Book Description

High-throughput Sequencing-based Investigation of Chronic Disease Markers and Mechanisms.

High-throughput Sequencing-based Investigation of Chronic Disease Markers and Mechanisms. PDF Author: Hua Li
Publisher: Frontiers Media SA
ISBN: 2889765598
Category : Science
Languages : en
Pages : 161

Get Book Here

Book Description


Bioinformatics of Genome Regulation, Volume I, 2nd Edition

Bioinformatics of Genome Regulation, Volume I, 2nd Edition PDF Author: Yuriy L. Orlov
Publisher: Frontiers Media SA
ISBN: 2889741427
Category : Science
Languages : en
Pages : 234

Get Book Here

Book Description
Publisher’s note: In this 2nd edition, the following article has been updated: Orlov YL, Tatarinova TV, Oparina NY, Galieva ER and Baranova AV (2021) Editorial: Bioinformatics of Genome Regulation, Volume I. Front. Genet. 12:803273. doi: 10.3389/fgene.2021.803273

Bioinformatics of Genome Regulation, Volume II

Bioinformatics of Genome Regulation, Volume II PDF Author: Yuriy L. Orlov
Publisher: Frontiers Media SA
ISBN: 288974177X
Category : Science
Languages : en
Pages : 203

Get Book Here

Book Description


How Tobacco Smoke Causes Disease

How Tobacco Smoke Causes Disease PDF Author: United States. Public Health Service. Office of the Surgeon General
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 728

Get Book Here

Book Description
This report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products.

Evolution of Translational Omics

Evolution of Translational Omics PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309224187
Category : Science
Languages : en
Pages : 354

Get Book Here

Book Description
Technologies collectively called omics enable simultaneous measurement of an enormous number of biomolecules; for example, genomics investigates thousands of DNA sequences, and proteomics examines large numbers of proteins. Scientists are using these technologies to develop innovative tests to detect disease and to predict a patient's likelihood of responding to specific drugs. Following a recent case involving premature use of omics-based tests in cancer clinical trials at Duke University, the NCI requested that the IOM establish a committee to recommend ways to strengthen omics-based test development and evaluation. This report identifies best practices to enhance development, evaluation, and translation of omics-based tests while simultaneously reinforcing steps to ensure that these tests are appropriately assessed for scientific validity before they are used to guide patient treatment in clinical trials.

Molecular Epidemiology

Molecular Epidemiology PDF Author: Paul A. Schulte
Publisher: Academic Press
ISBN: 0323138578
Category : Medical
Languages : en
Pages : 609

Get Book Here

Book Description
This book will serve as a primer for both laboratory and field scientists who are shaping the emerging field of molecular epidemiology. Molecular epidemiology utilizes the same paradigm as traditional epidemiology but uses biological markers to identify exposure, disease or susceptibility. Schulte and Perera present the epidemiologic methods pertinent to biological markers. The book is also designed to enumerate the considerations necessary for valid field research and provide a resource on the salient and subtle features of biological indicators.

Association Between Individuals’ Genomic Ancestry and Variation in Disease Susceptibility

Association Between Individuals’ Genomic Ancestry and Variation in Disease Susceptibility PDF Author: Ranajit Das
Publisher: Frontiers Media SA
ISBN: 2889745716
Category : Science
Languages : en
Pages : 149

Get Book Here

Book Description
Topic Editor Ranajit Das is the Founder Director of Genome Mapster and Infygene Genomic Healthcare. Topic Editor Tatiana Tatarinova holds patents related to the Research Topic subject. All other Topic Editors declare no competing interests with regard to the Research Topic subject.

Genes, Behavior, and the Social Environment

Genes, Behavior, and the Social Environment PDF Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309101964
Category : Social Science
Languages : en
Pages : 385

Get Book Here

Book Description
Over the past century, we have made great strides in reducing rates of disease and enhancing people's general health. Public health measures such as sanitation, improved hygiene, and vaccines; reduced hazards in the workplace; new drugs and clinical procedures; and, more recently, a growing understanding of the human genome have each played a role in extending the duration and raising the quality of human life. But research conducted over the past few decades shows us that this progress, much of which was based on investigating one causative factor at a time—often, through a single discipline or by a narrow range of practitioners—can only go so far. Genes, Behavior, and the Social Environment examines a number of well-described gene-environment interactions, reviews the state of the science in researching such interactions, and recommends priorities not only for research itself but also for its workforce, resource, and infrastructural needs.

Molecular Mechanisms in Chronic Kidney Disease

Molecular Mechanisms in Chronic Kidney Disease PDF Author: Claudia Torino
Publisher: Frontiers Media SA
ISBN: 2889712583
Category : Science
Languages : en
Pages : 282

Get Book Here

Book Description


Integrative Multi-Omics for Diagnosis, Treatments, and Drug Discovery of Aging-Related Neuronal Diseases

Integrative Multi-Omics for Diagnosis, Treatments, and Drug Discovery of Aging-Related Neuronal Diseases PDF Author: Min Tang
Publisher: Frontiers Media SA
ISBN: 2832506674
Category : Science
Languages : en
Pages : 224

Get Book Here

Book Description
As the cost of high-throughput sequencing goes down, huge volumes of biological and medical data have been produced from various sequencing platforms at multiple molecular levels including genome, transcriptome, proteome, epigenome, metabolome, and so on. For a long time, data analysis on single molecular levels has paved the way to answer many important research questions. However, many Aging-Related Neuronal Diseases (ARNDs) and Central Nervous System (CNS) aging involve interactions of molecules from multiple molecular levels, in which conclusions based on single molecular levels are usually incomplete and sometimes misleading. In these scenarios, multi-omics data analysis has unprecedentedly helped capture much more useful information for the diagnosis, treatment, prognosis, and drug discovery of ARNDs. The first step towards a multi-omics analysis is to establish reliable and robust multi-omics datasets. In the past years, a few important ARNDs-associated multi-omics databases like Allen Brain have been constructed, which raised immediate needs like data curation, normalization, interpretation, and visualization for integrative multi-omics explorations. Though there have been several well-established multi-omics databases for ARNDs like Alzheimer’s disease, similar databases for other ARNDs are still in urgent need. After the databases establish, many computational tools and experiential strategies should be developed specifically for them. First, the multi-omics data are usually extremely noisy, complex, heterogeneous and in high dimension, which presents the need for appropriate denoising and dimension reduction methods. Second, since the multi-omics and non-omics data like pathological and clinical data are usually in different data spaces, a useful algorithm to mapping them into the same data space and integrate them is nontrivial. In the multi-omics era, there are numerous data-centric tools for the integration of multi-omics datasets, which could be generally divided into three categories: unsupervised, supervised, and semi-supervised methods. Commonly used algorithms include but not limited to Bayesian-based methods, Network-based methods, multi-step analysis methods, and multiple kernel learning methods. Third, methods are needed in studying and verifying the association between two or more levels of multi-omics data and non-omics data. For example, expression quantitative trait loci (eQTL) analysis is widely used to infer the association between a single nucleotide polymorphism (SNP) and the expression of a gene. Recently, the association between omics data and more complex data like pathological and clinical imaging data has been a hot research topic. The outcomes may reveal the underlying molecular mechanism and promote de novo drug design as well as drug repurposing for ARNDs. Here, we welcome investigators to share their Original Research, Review, Mini Review, Hypothesis and Theory, Perspective, Conceptual Analysis, Data Report, Brief Research Report, Code related to multi-omics studies of ARNDs, which can be applied for better diagnosis, treatment, prognosis and drug discovery of human diseases in the future era of precision medicine. Potential contents include but are not limited to the following: ▪ Methods for integrating, interpreting, or visualizing two or more omics data. ▪ Methods for identifying interactions between different data modalities. ▪ Methods for disease subtyping, biomarker prediction. ▪ Machine learning or deep learning methods on dimensional reduction and feature selection for big noisy data. ▪ Methods for studying the association among different omics data or between omics and non-omics data like clinical, pathological, and imaging data. ▪ Review of multi-omics resource about ARNDs and/or CNS aging. ▪ Experimental validation of biomarkers identified from multi-omics data analysis. ▪ Disease diagnosis and prognosis prediction from imaging and non-imaging data analysis, or both. ▪ Clinical applications or validations of findings from multi-omics data analysis.